Summit Securities Group’s Johnson & Johnson JNJ Stock Holding History

Summit Securities Group’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,526	Closed	-$373K	–	1267
2026 Q1	$373K	Sell	1,526 -3,466	-69%	-$807K	0.05%	171
2025 Q4	$1.03M	Sell	4,992 -1,680	-25%	-$332K	0.13%	129
2025 Q3	$1.24M	Buy	6,672 +3,990	+149%	+$684K	0.26%	86
2025 Q2	$410K	Buy	+2,682	New	+$412K	0.08%	158
2023 Q3	–	Sell	-3,684	Closed	-$608K	–	807
2023 Q2	$610K	Sell	3,684 -222	-6%	-$35.8K	0.08%	123
2023 Q1	$605K	Sell	3,906 -3,164	-45%	-$511K	0.05%	123
2022 Q4	$1.25M	Sell	7,070 -245	-3%	-$42.3K	0.05%	156
2022 Q3	$1.2M	Sell	7,315 -4,970	-40%	-$841K	0.09%	148
2022 Q2	$2.18M	Buy	12,285 +2,496	+25%	+$445K	0.27%	69
2022 Q1	$1.74M	Sell	9,789 -8,411	-46%	-$1.43M	0.19%	94
2021 Q4	$3.11M	Sell	18,200 -16,083	-47%	-$2.63M	0.15%	115
2021 Q3	$5.54M	Buy	34,283 +5,346	+18%	+$912K	0.43%	51
2021 Q2	$4.77M	Buy	28,937 +11,837	+69%	+$1.96M	0.39%	53
2021 Q1	$2.81M	Buy	17,100 +6,800	+66%	+$1.1M	0.31%	68
2020 Q4	$1.62M	Buy	10,300 +2,300	+29%	+$339K	0.14%	174
2020 Q3	$1.19M	Sell	8,000 -200	-2%	-$29.6K	0.12%	139
2020 Q2	$1.15M	Sell	8,200 -22,500	-73%	-$3.28M	0.14%	137
2020 Q1	$4.03M	Buy	+30,700	New	+$4.36M	0.71%	37
2019 Q1	–	Sell	-3,100	Closed	-$400K	–	286
2018 Q4	$400K	Sell	3,100 -13,900	-82%	-$1.94M	0.03%	220
2018 Q3	$2.35M	Buy	17,000 +14,700	+639%	+$1.95M	0.87%	23
2018 Q2	$279K	Sell	2,300 -5,500	-71%	-$686K	0.04%	186
2018 Q1	$1M	Sell	7,800 -14,200	-65%	-$1.92M	0.24%	57
2017 Q4	$3.07M	Buy	22,000 +15,800	+255%	+$2.2M	0.37%	26
2017 Q3	$806K	Buy	6,200 +2,240	+57%	+$297K	0.14%	72
2017 Q2	$524K	Sell	3,960 -4,140	-51%	-$528K	0.09%	121
2017 Q1	$1.01M	Sell	8,100 -20,700	-72%	-$2.47M	0.29%	67
2016 Q4	$3.32M	Buy	+28,800	New	+$3.33M	0.72%	28
2016 Q3	–	Sell	-3,300	Closed	-$400K	–	219
2016 Q2	$400K	Buy	+3,300	New	+$375K	0.21%	112
2016 Q1	–	Sell	-3,500	Closed	-$360K	–	240
2015 Q4	$360K	Sell	3,500 -3,400	-49%	-$342K	0.12%	126
2015 Q3	$644K	Buy	6,900 +3,399	+97%	+$329K	0.46%	38
2015 Q2	$341K	Buy	3,501 +601	+21%	+$60.2K	0.17%	44
2015 Q1	$292K	Sell	2,900 -48,100	-94%	-$4.89M	0.22%	64
2014 Q4	$5.33M	Buy	51,000 +14,500	+40%	+$1.53M	1.53%	10
2014 Q3	$3.89M	Buy	36,500 +27,800	+320%	+$2.88M	1.13%	24
2014 Q2	$910K	Buy	8,700 +6,100	+235%	+$617K	0.31%	54
2014 Q1	$255K	Sell	2,600 -107,400	-98%	-$9.96M	0.15%	82
2013 Q4	$10.1M	Buy	110,000 +15,800	+17%	+$1.46M	1.75%	9
2013 Q3	$8.17M	Sell	94,200 -80,900	-46%	-$7.26M	2.78%	7
2013 Q2	$15M	Buy	+175,100	New	+$14.9M	7.18%	2

Other funds holding JNJ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Summit Securities Group's JNJ Position: Q2 2026 in Review

Summit Securities Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,526 shares — an estimated $373K sold.

Summit Securities Group first reported a position in JNJ in Q2 2013 and held it in 39 quarters. The position peaked at $15M in Q2 2013. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

Summit Securities Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 1,526 Johnson & Johnson shares in Q2 2026, an estimated $373K.
Summit Securities Group first reported a position in Johnson & Johnson in Q2 2013 and held it in 39 quarters.
Summit Securities Group's Johnson & Johnson position peaked at $15M in Q2 2013.
4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.